RU95102323A - Производные 5,6,7,8-тетрагидро-имидазо [1,2-a]-пиридина, способ их получения, содержащая их композиция и способ ее получения - Google Patents
Производные 5,6,7,8-тетрагидро-имидазо [1,2-a]-пиридина, способ их получения, содержащая их композиция и способ ее полученияInfo
- Publication number
- RU95102323A RU95102323A RU95102323/04A RU95102323A RU95102323A RU 95102323 A RU95102323 A RU 95102323A RU 95102323/04 A RU95102323/04 A RU 95102323/04A RU 95102323 A RU95102323 A RU 95102323A RU 95102323 A RU95102323 A RU 95102323A
- Authority
- RU
- Russia
- Prior art keywords
- preparation
- derivatives
- composition
- tetrahydroimidazo
- pyridine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Соединения формулыа также соответствующие производные 5,6,7,8-тетрагидроимидазо[1,2-а] пиридина, их физиологически приемлемые соли и/или сольваты, подавляют связывание фибриногена с соответствующим рецептором и могут применяться для лечения тромбозов, остеопрозов, опухолевых заболеваний, апоплексии, инфаркта сердца, воспалений, артериосклероза и остеолитических заболеваний.
Claims (1)
- Соединения формулы
а также соответствующие производные 5,6,7,8-тетрагидроимидазо[1,2-а] пиридина, их физиологически приемлемые соли и/или сольваты, подавляют связывание фибриногена с соответствующим рецептором и могут применяться для лечения тромбозов, остеопрозов, опухолевых заболеваний, апоплексии, инфаркта сердца, воспалений, артериосклероза и остеолитических заболеваний.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4405378A DE4405378A1 (de) | 1994-02-19 | 1994-02-19 | Adhäsionsrezeptor-Antagonisten |
DEP4405378.9 | 1994-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU95102323A true RU95102323A (ru) | 1997-03-20 |
Family
ID=6510687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95102323/04A RU95102323A (ru) | 1994-02-19 | 1995-02-17 | Производные 5,6,7,8-тетрагидро-имидазо [1,2-a]-пиридина, способ их получения, содержащая их композиция и способ ее получения |
Country Status (15)
Country | Link |
---|---|
US (1) | US5614531A (ru) |
EP (1) | EP0668278A1 (ru) |
JP (1) | JPH07252254A (ru) |
KR (1) | KR950032197A (ru) |
CN (1) | CN1111630A (ru) |
AU (1) | AU1230795A (ru) |
CA (1) | CA2142741A1 (ru) |
CZ (1) | CZ42495A3 (ru) |
DE (1) | DE4405378A1 (ru) |
HU (1) | HUT71806A (ru) |
NO (1) | NO950606L (ru) |
PL (1) | PL307328A1 (ru) |
RU (1) | RU95102323A (ru) |
SK (1) | SK22195A3 (ru) |
ZA (1) | ZA951345B (ru) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040084945A (ko) * | 1996-07-25 | 2004-10-06 | 바이오겐 아이덱 엠에이 인코포레이티드 | 세포 유착 억제제 |
DE19653646A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung |
AR011057A1 (es) * | 1997-01-08 | 2000-08-02 | Smithkline Beecham Corp | Uso de bis-acridinas sustituidas y compuestos afines para la preparacion de medicamentos y dichos compuestos |
US5902797A (en) * | 1997-11-10 | 1999-05-11 | Beth Israel Deaconess Medical Center | Nutritional supplement for use in the treatment of attention deficit |
EP1140194A2 (en) | 1998-12-23 | 2001-10-10 | G.D. SEARLE & CO. | Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia |
DE10117183A1 (de) * | 2001-04-05 | 2002-10-10 | Gruenenthal Gmbh | Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel |
DE10117184A1 (de) * | 2001-04-05 | 2002-10-17 | Gruenenthal Gmbh | Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen |
EP2484365B1 (en) | 2004-06-04 | 2013-10-02 | The Scripps Research Institute | Compositions and method for treatment of neovascular diseases |
KR20070101227A (ko) | 2004-09-07 | 2007-10-16 | 아케믹스 코포레이션 | 폰 빌레브란트 인자에 대한 앱타머 및 이의 혈전증치료제로서의 용도 |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
US20070066551A1 (en) * | 2004-09-07 | 2007-03-22 | Keefe Anthony D | Aptamer medicinal chemistry |
EP1965807A4 (en) * | 2005-11-23 | 2010-10-27 | Epix Delaware Inc | S1P RECEPTOR MODULATING COMPOUNDS AND THEIR USE |
US7919519B2 (en) * | 2005-11-23 | 2011-04-05 | Epix Pharmaceuticals Inc. | S1P receptor modulating compounds and use thereof |
EP1966201A1 (en) * | 2005-11-28 | 2008-09-10 | Mallinckrodt, Inc. | Improved method of preparation for imidazolepyridines |
CL2007000742A1 (es) * | 2006-03-21 | 2008-01-11 | Epix Delaware Inc | Compuestos derivados de 2-oxoimidazol, moduladores del recptor s1p (esfingosina-1-fosfato); composicion farmceutica que los contiene; y su uso para tratar condiciones tales como rechazo de trasplante, cancer, artritis reumatoide y diabetes. |
WO2008027812A2 (en) * | 2006-08-28 | 2008-03-06 | Forest Laboratories Holdings Limited | Imidazopyridine and imidazopyrimidine derivatives |
EP1964840A1 (en) | 2007-02-28 | 2008-09-03 | sanofi-aventis | Imidazo[1,2-a]pyridines and their use as pharmaceuticals |
AU2007227278B2 (en) * | 2007-03-21 | 2014-09-11 | Epix Pharmaceuticals, Inc. | SIP receptor modulating compounds and use thereof |
US20090203766A1 (en) * | 2007-06-01 | 2009-08-13 | Archemix Corp. | vWF aptamer formulations and methods for use |
EP2188252B1 (en) * | 2007-09-20 | 2011-04-13 | Amgen Inc. | 1-(4-(4-benzylbenzamido)-benzyl)azetidine-3-carboxylic acid derivatives and related compounds as s1p receptor modulators for the treatment of immune disorders |
US7868001B2 (en) * | 2007-11-02 | 2011-01-11 | Hutchison Medipharma Enterprises Limited | Cytokine inhibitors |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2032455T3 (es) * | 1986-01-22 | 1993-02-16 | Synthelabo | Procedimiento para preparar derivados de 3-acilaminometil-imidazo (-1,2-a)piridinas. |
FR2593818B1 (fr) * | 1986-02-05 | 1988-04-29 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique |
US4990506A (en) * | 1986-02-05 | 1991-02-05 | Synthelabo | 3-(acylaminomethyl)imidazo[1,2-a]pyridine derivatives and their application in therapy |
US4791117A (en) * | 1986-09-22 | 1988-12-13 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers |
FR2606410B1 (fr) * | 1986-11-07 | 1989-02-24 | Synthelabo | Imidazopyridines, leur preparation et leur application en therapeutique |
US5053393A (en) * | 1988-07-20 | 1991-10-01 | Monsanto Company | Novel platelet-aggregation inhibitor |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
US5256812A (en) * | 1989-01-31 | 1993-10-26 | Hoffmann-La Roche Inc. | Carboxamides and sulfonamides |
DE4017211A1 (de) * | 1990-05-29 | 1991-12-05 | Merck Patent Gmbh | Oxazolidinone |
HUT68769A (en) * | 1991-05-07 | 1995-07-28 | Merck & Co Inc | FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE |
US5321034A (en) * | 1991-05-07 | 1994-06-14 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
DE4129603A1 (de) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US5272158A (en) * | 1991-10-29 | 1993-12-21 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
WO1993019066A1 (en) * | 1992-03-17 | 1993-09-30 | Nippon Shinyaku Co., Ltd. | Imidazopyridine derivative and medicine |
DE4327027A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
-
1994
- 1994-02-19 DE DE4405378A patent/DE4405378A1/de not_active Withdrawn
-
1995
- 1995-02-14 EP EP95101992A patent/EP0668278A1/de not_active Withdrawn
- 1995-02-15 CN CN95101977A patent/CN1111630A/zh active Pending
- 1995-02-16 AU AU12307/95A patent/AU1230795A/en not_active Abandoned
- 1995-02-17 NO NO950606A patent/NO950606L/no unknown
- 1995-02-17 ZA ZA951345A patent/ZA951345B/xx unknown
- 1995-02-17 US US08/390,669 patent/US5614531A/en not_active Expired - Fee Related
- 1995-02-17 CZ CZ95424A patent/CZ42495A3/cs unknown
- 1995-02-17 RU RU95102323/04A patent/RU95102323A/ru unknown
- 1995-02-17 PL PL95307328A patent/PL307328A1/xx unknown
- 1995-02-17 CA CA002142741A patent/CA2142741A1/en not_active Abandoned
- 1995-02-17 JP JP7029649A patent/JPH07252254A/ja active Pending
- 1995-02-17 SK SK221-95A patent/SK22195A3/sk unknown
- 1995-02-17 HU HU9500479A patent/HUT71806A/hu unknown
- 1995-02-18 KR KR1019950003141A patent/KR950032197A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO950606L (no) | 1995-08-21 |
HUT71806A (en) | 1996-02-28 |
AU1230795A (en) | 1995-08-31 |
PL307328A1 (en) | 1995-08-21 |
SK22195A3 (en) | 1995-09-13 |
CZ42495A3 (en) | 1995-10-18 |
JPH07252254A (ja) | 1995-10-03 |
US5614531A (en) | 1997-03-25 |
CA2142741A1 (en) | 1995-08-20 |
KR950032197A (ko) | 1995-12-20 |
DE4405378A1 (de) | 1995-08-24 |
CN1111630A (zh) | 1995-11-15 |
HU9500479D0 (en) | 1995-04-28 |
ZA951345B (en) | 1995-10-24 |
NO950606D0 (no) | 1995-02-17 |
EP0668278A1 (de) | 1995-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95102323A (ru) | Производные 5,6,7,8-тетрагидро-имидазо [1,2-a]-пиридина, способ их получения, содержащая их композиция и способ ее получения | |
RU94041198A (ru) | Производные имидазопиридазина, способ их получения, содержащая их фармацевтическая композиция, способ ее получения | |
EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA200001223A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA199900494A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA200001224A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA200000759A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
YU69991A (sh) | Derivati piridina | |
BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
EA199901015A1 (ru) | 4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а | |
EA200100127A1 (ru) | Производные фенилксантина | |
HUT70541A (en) | Adhesion receptor antagonists, pharmaceutical compositions comprising them and process for their preparation | |
RU94042907A (ru) | Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ ее получения | |
RU94042935A (ru) | Водорастворенные комплексы включения соединений бензотиофена с водорастворимыми циклодекстринами, способ их получения и фармацевтический состав | |
EE03262B1 (et) | Imidaso[1,2-a]püridiinidest saadavad alkoksüalküülkarbamaadid, nende valmistamine ja kasutamine | |
DE68906609T2 (de) | Dopamin-vorlaeufer. | |
AU655288B2 (en) | New triazolopyrimidine derivatives which are angiotensin II receptor antagonists; processes for preparing them and pharmaceutical compositions containing them | |
RU95110937A (ru) | Хинолоновые и акридиноновые соединения, способ их получения, фармацевтическая композиция и промежуточные соединения | |
RU93004860A (ru) | Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция | |
RU94038256A (ru) | Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе | |
RU95106680A (ru) | Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции | |
NO995431L (no) | Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse | |
HUT51221A (en) | Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients | |
AU6216586A (en) | New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren |